Snapshot
-
MODULATION OF LYMPHATIC VESSELS IN MANAGEMENT OF LIVER DISEASE AND COMPLICATIONS
- Aarti Sharma, Pinky Juneja, Shiv K Sarin, Savneet Kaur
- DOI: 10.3350/cmh.2024.0793 [Epub ahead of print]
-
Metabolic dysfunction-associated steatotic liver disease across women’s reproductive lifespan and issues
- Clara Meda, Arianna Dolce, Sara Della Torre
- Clin Mol Hepatol. 2025;31(1):327-332.
-
Examining the therapeutic landscape of beta-blockers in portal hypertension
- Anna Brujats, Càndid Villanueva
- Clin Mol Hepatol. 2024;30(4):1055-1059.
-
Immunopathogenesis of liver fibrosis in steatotic liver disease
- Chaerin Woo, Won-Il Jeong
- Clin Mol Hepatol. 2024;30(2):299-302.
-
Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Xinyi Lu, Rui Yang, Yu Chen, Daozhen Chen
- Clin Mol Hepatol. 2024;30(3):582-584.
-
Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- Young Chang, Soung Won Jeong, Jae Young Jang
- Clin Mol Hepatol. 2024;30(1):129-133.
-
The role of the hepatic autonomic nervous system
- Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin
- Clin Mol Hepatol. 2023;29(4):1052-1055.
-
HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Soon Kyu Lee, Jung Hyun Kwon
- Clin Mol Hepatol. 2023;29(3):825-827.
-
Systemic therapy in advanced hepatocellular carcinoma
- Joseph C. Ahn, Nguyen H. Tran, Ju Dong Yang
- Clin Mol Hepatol. 2023;29(2):516-519.
-
Epidemiology and updated management for autoimmune liver disease
- Nae-Yun Heo, Haeryoung Kim
- Clin Mol Hepatol. 2023;29(1):194-196.
-
Microbiome and metabolomics in alcoholic liver disease
- Raja Ganesan, Ki Tae Suk
- Clin Mol Hepatol. 2022;28(3):580-582.
-
Personalized medicine in nonalcoholic fatty liver disease
- Carlos J. Pirola, Silvia Sookoian
- Clin Mol Hepatol. 2022;28(4):935-938.
-
Acute on chronic liver failure in cirrhosis
- Marta Tonon, Salvatore Piano
- Clin Mol Hepatol. 2022;28(2):273-275.
-
Current status and outcome of liver transplantation in South Korea
- Ho Joong Choi
- Clin Mol Hepatol. 2022;28(1):117-119.
-
History and future of hepatitis B virus control in South Korea
- Do Young Kim
- Clin Mol Hepatol. 2021;27(4):620-622.
-
Hepatocellular carcinoma statistics in South Korea
- Young Eun Chon, Soung Won Jeong, Dae Won Jun
- Clin Mol Hepatol. 2021;27(3):512-514.
